Skip to main content

Table 1 Demographic data

From: Effectiveness of betadine-coating gastrostomy tube to reduce peristomal infection after percutaneous endoscopic gastrostomy: a randomized controlled trial

Patient Demographic

All (N = 50)

Betadine (N = 25)

Control (N = 25)

p value

Age (years)

69.5 (55.7–86)

73 (55-87.5)

69 (55.5–83)

0.712

Sex (M/F) (%)

29 (58%)/21 (42%)

14 (58.3%)/10 (41.7%)

15 (57.7%)/11 (42.3%)

0.963

BMI

19.99 (17.89–23.23)

18.98 (17.38–23.06)

21.30 (18.41–23.82)

0.443

Head and neck cancer (%)

7 (14%)

5 (20%)

2 (8%)

0.417

CVA (%)

17 (34%)

6 (24%)

11 (44%)

0.232

HTN (%)

28 (56%)

14 (56%)

14 (56%)

1.000

DM (%)

14 (28%)

6 (24%)

8 (30.8%)

0.754

Dementia (%)

17 (34%)

9 (36%)

8 (32%)

0.765

ALS (%)

15 (30%)

6 (24%)

9 (36%)

0.355

Biochemistry

    

Albumin-before (g/dl)

3.7 (3.3–4.1)

3.7 (3.0–4.0)

3.7 (3.3–4.1)

0.690

WBC-before (cumm)

6.8 (5.8–8.4)

6.3 (5.4–8.3)

7.5 (6.1–8.5)

0.252

 N/L ratio-before

3.2 (2.6–4.4)

3.2 (2.2–4.3)

3.3 (2.6–4.6)

0.778

CRP-before (mg/dl)

0.27 (0.09–1.07)

0.27 (0.09–1.15)

0.23 (0.09–1.24)

0.854

WBC-after (cumm)

9.0 (6.8–10.6)

8.3 (6.2–10.2)

9.3 (8.1–11.5)

0.099

 N/L ratio-after

5.5 (3.5–7.4)

4.6 (3.1–6.4)

6.3 (3.6–8.1)

0.052

CRP-after (mg/dl)

2.64 (1.06–5.01)

1.91 (0.79–3.14)

3.62 (1.52–5.44)

0.076

Delta WBC (cumm)

1.6 (0.2–3.7)

1.3 (-0.1-3.0)

1.8 (0.4–4.6)

0.225

Delta N/L ratio

1.4 (0.4–3.8)

1.2 (0-2.7)

3.1 (0.7–4.4)

0.047

Delta CRP (mg/dl)

1.75 (0.77–3.01)

1.16 (0.51-2.00)

2.68 (1.36–4.1)

0.009

Total time (min)

20.5 (18-27.3)

20 (18–28)

21 (17–27)

0.869

PEG procedure time (min)

9 (6–10)

9 (6.5–11)

8 (6-9.5)

0.068

Fever (%)

3 (6%)

0

3 (12%)

0.235

Total peristomal wound infection (%)

10 (20%)

6 (24%)

4 (16%)

0.725

Total pneumonia (%)

5 (10%)

1 (4%)

4 (16%)

0.349

Total stomal leakage (%)

8 (16%)

5 (20%)

3 (12%)

0.702

All-cause infection (%)

13 (26%)

6 (24%)

7 (28%)

0.725

Admission days

6.5 (4–11)

7 (4-10.5)

6 (4–13)

0.770